← Back to the boardNews
STAT+: Democrats take new step toward investigating Trump’s drug pricing deals
Why it’s here: Congressional oversight of MFN drug pricing deals is a federal policy fight in biotechnology/pharma policy, though it leans toward drug-pricing rules, which the biotech scope covers only when they affect innovation.
Trace across the boardItem
4d agoSTATSTAT+: Democrats take new step toward investigating Trump’s drug pricing dealsIncoming Democratic committee chairs sent a fresh round of letters to all 27 drugmakers demanding details of their Trump administration most-favored-nation pricing deals.1 outlet4 linked
Connected
4 links- NewsTop trade committee Democrats launch probe into Trump administration approving Nvidia's chip sales to ChinaBoth involve Senate Finance Committee Democrats, House Committee on Ways and Means
- HillH.R. 3521: Clinical Trial Modernization ActBoth involve House Energy and Commerce Committee, House Committee on Ways and Means
- HillH.R. 10857: Faster Clinical Trials ActBoth involve House Energy and Commerce Committee, House Committee on Ways and Means
- HillH.R. 4640: Stop AI Price Gouging and Wage Fixing Act of 2025Both involve House Energy and Commerce Committee, House Education and Labor Committee
About
- House Energy and Commerce Committee
- Trump administration
- Senate Finance Committee Democrats
- Medicaid
- House Committee on Ways and Means
- House Education and Labor Committee